The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Platelet-rich Plasma Therapy Market Research Report 2025

Global Platelet-rich Plasma Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1896916

No of Pages : 82

Ask Your Query
Synopsis
Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
The global Platelet-rich Plasma Therapy market was valued at US$ 722 million in 2023 and is anticipated to reach US$ 1919.8 million by 2030, witnessing a CAGR of 15.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Platelet-rich Plasma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platelet-rich Plasma Therapy.
Report Scope
The Platelet-rich Plasma Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Platelet-rich Plasma Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Platelet-rich Plasma Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Terumo
Arthrex
Zimmer Biomet
J & J
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics
Segment by Type
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)
Segment by Application
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Platelet-rich Plasma Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Platelet-rich Plasma Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pure PRP
1.2.3 Leucocyte-rich PRP
1.2.4 Leukocyte-rich Fibrin (L-PRF)
1.3 Market by Application
1.3.1 Global Platelet-rich Plasma Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Orthopedic
1.3.3 Darmatology
1.3.4 Cardiac Muscle Injury
1.3.5 Dental
1.3.6 Nerve Injury
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Platelet-rich Plasma Therapy Market Perspective (2019-2030)
2.2 Platelet-rich Plasma Therapy Growth Trends by Region
2.2.1 Global Platelet-rich Plasma Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Platelet-rich Plasma Therapy Historic Market Size by Region (2019-2024)
2.2.3 Platelet-rich Plasma Therapy Forecasted Market Size by Region (2025-2030)
2.3 Platelet-rich Plasma Therapy Market Dynamics
2.3.1 Platelet-rich Plasma Therapy Industry Trends
2.3.2 Platelet-rich Plasma Therapy Market Drivers
2.3.3 Platelet-rich Plasma Therapy Market Challenges
2.3.4 Platelet-rich Plasma Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Platelet-rich Plasma Therapy Players by Revenue
3.1.1 Global Top Platelet-rich Plasma Therapy Players by Revenue (2019-2024)
3.1.2 Global Platelet-rich Plasma Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Platelet-rich Plasma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Platelet-rich Plasma Therapy Revenue
3.4 Global Platelet-rich Plasma Therapy Market Concentration Ratio
3.4.1 Global Platelet-rich Plasma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Platelet-rich Plasma Therapy Revenue in 2023
3.5 Platelet-rich Plasma Therapy Key Players Head office and Area Served
3.6 Key Players Platelet-rich Plasma Therapy Product Solution and Service
3.7 Date of Enter into Platelet-rich Plasma Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Platelet-rich Plasma Therapy Breakdown Data by Type
4.1 Global Platelet-rich Plasma Therapy Historic Market Size by Type (2019-2024)
4.2 Global Platelet-rich Plasma Therapy Forecasted Market Size by Type (2025-2030)
5 Platelet-rich Plasma Therapy Breakdown Data by Application
5.1 Global Platelet-rich Plasma Therapy Historic Market Size by Application (2019-2024)
5.2 Global Platelet-rich Plasma Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Platelet-rich Plasma Therapy Market Size (2019-2030)
6.2 North America Platelet-rich Plasma Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Platelet-rich Plasma Therapy Market Size by Country (2019-2024)
6.4 North America Platelet-rich Plasma Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Platelet-rich Plasma Therapy Market Size (2019-2030)
7.2 Europe Platelet-rich Plasma Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Platelet-rich Plasma Therapy Market Size by Country (2019-2024)
7.4 Europe Platelet-rich Plasma Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Platelet-rich Plasma Therapy Market Size (2019-2030)
8.2 Asia-Pacific Platelet-rich Plasma Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Platelet-rich Plasma Therapy Market Size (2019-2030)
9.2 Latin America Platelet-rich Plasma Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Platelet-rich Plasma Therapy Market Size by Country (2019-2024)
9.4 Latin America Platelet-rich Plasma Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Platelet-rich Plasma Therapy Market Size (2019-2030)
10.2 Middle East & Africa Platelet-rich Plasma Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Terumo
11.1.1 Terumo Company Detail
11.1.2 Terumo Business Overview
11.1.3 Terumo Platelet-rich Plasma Therapy Introduction
11.1.4 Terumo Revenue in Platelet-rich Plasma Therapy Business (2019-2024)
11.1.5 Terumo Recent Development
11.2 Arthrex
11.2.1 Arthrex Company Detail
11.2.2 Arthrex Business Overview
11.2.3 Arthrex Platelet-rich Plasma Therapy Introduction
11.2.4 Arthrex Revenue in Platelet-rich Plasma Therapy Business (2019-2024)
11.2.5 Arthrex Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Detail
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Platelet-rich Plasma Therapy Introduction
11.3.4 Zimmer Biomet Revenue in Platelet-rich Plasma Therapy Business (2019-2024)
11.3.5 Zimmer Biomet Recent Development
11.4 J & J
11.4.1 J & J Company Detail
11.4.2 J & J Business Overview
11.4.3 J & J Platelet-rich Plasma Therapy Introduction
11.4.4 J & J Revenue in Platelet-rich Plasma Therapy Business (2019-2024)
11.4.5 J & J Recent Development
11.5 EmCyte
11.5.1 EmCyte Company Detail
11.5.2 EmCyte Business Overview
11.5.3 EmCyte Platelet-rich Plasma Therapy Introduction
11.5.4 EmCyte Revenue in Platelet-rich Plasma Therapy Business (2019-2024)
11.5.5 EmCyte Recent Development
11.6 Regen Lab
11.6.1 Regen Lab Company Detail
11.6.2 Regen Lab Business Overview
11.6.3 Regen Lab Platelet-rich Plasma Therapy Introduction
11.6.4 Regen Lab Revenue in Platelet-rich Plasma Therapy Business (2019-2024)
11.6.5 Regen Lab Recent Development
11.7 ISTO Biologics
11.7.1 ISTO Biologics Company Detail
11.7.2 ISTO Biologics Business Overview
11.7.3 ISTO Biologics Platelet-rich Plasma Therapy Introduction
11.7.4 ISTO Biologics Revenue in Platelet-rich Plasma Therapy Business (2019-2024)
11.7.5 ISTO Biologics Recent Development
11.8 Cesca Therapeutics
11.8.1 Cesca Therapeutics Company Detail
11.8.2 Cesca Therapeutics Business Overview
11.8.3 Cesca Therapeutics Platelet-rich Plasma Therapy Introduction
11.8.4 Cesca Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2019-2024)
11.8.5 Cesca Therapeutics Recent Development
11.9 Weigao
11.9.1 Weigao Company Detail
11.9.2 Weigao Business Overview
11.9.3 Weigao Platelet-rich Plasma Therapy Introduction
11.9.4 Weigao Revenue in Platelet-rich Plasma Therapy Business (2019-2024)
11.9.5 Weigao Recent Development
11.10 REV-MED
11.10.1 REV-MED Company Detail
11.10.2 REV-MED Business Overview
11.10.3 REV-MED Platelet-rich Plasma Therapy Introduction
11.10.4 REV-MED Revenue in Platelet-rich Plasma Therapy Business (2019-2024)
11.10.5 REV-MED Recent Development
11.11 Nuo Therapeutics
11.11.1 Nuo Therapeutics Company Detail
11.11.2 Nuo Therapeutics Business Overview
11.11.3 Nuo Therapeutics Platelet-rich Plasma Therapy Introduction
11.11.4 Nuo Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2019-2024)
11.11.5 Nuo Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock